Nexviadyme

Medicinal product

(Invented) name

Nexviadyme

Active substance (s)

Avalgliukozidazė alfa

Strength

100 mg

Pharmaceutical form

milteliai infuzinio tirpalo koncentratui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A16AB22, avalglucosidase alfa

Marketing authorisation holder

Sanofi B.V., Nyderlandai

Date of authorisation

2022-06-24

Date of renewal

Documents

Nexviadyme mokomoji medziaga sveikatos prieziuros specialistams.pdf

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Powder for concentrate for solution for infusion	1 vnt.
Avalgliukozidazė alfa	100 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
108929	95035	1095035	flakonas	N1		Receptinis	EU/1/21/1579/001	Netiekiama	-	-	No	-	-
108930	95036	1095036	flakonas	N5		Receptinis	EU/1/21/1579/002	Netiekiama	-	-	No	-	-
108931	95037	1095037	flakonas	N10		Receptinis	EU/1/21/1579/003	Netiekiama	-	-	No	-	-
108932	95038	1095038	flakonas	N25		Receptinis	EU/1/21/1579/004	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-06-24	Registruotas